New Antiviral Drug Appears As Effective As Nirmatrelvir/Ritonavir At Curbing Mild To Moderate COVID-19 Illness Among People At High Risk Of Severe Disease In Trial

NBC News (12/29, Bendix) reports a new antiviral drug “for Covid was found to be as effective as” nirmatrelvir/ritonavir (Paxlovid) “at curbing mild to moderate illness among people at high risk of severe disease in a phase 3 trial in China.” According to...